Bruker Corp (BRKR): Cash & Equivalents
$298.80M
As of 2025-12-31
$184.90M
As of 2026-06-30
-22.6%
3-year compound annual growth
-15.2%
5-year compound annual growth
+1.1%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $298.80M | +62.9% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $183.40M | -62.4% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $488.30M | -24.4% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $645.50M | -39.6% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $1.07B | +56.7% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $681.80M | +0.5% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $678.30M | +110.4% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $322.40M | -0.8% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $325.00M | -5.1% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $342.40M | +28.2% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $267.10M | -16.4% | 2017-03-01, Balance as of period end |
| 2014-12-31 | $319.50M | -27.2% | 2017-03-01, Balance as of period end |
| 2013-12-31 | $438.70M | +41.2% | 2016-02-29, Balance as of period end |
| 2012-12-31 | $310.60M | +26.3% | 2015-02-27, Balance as of period end |
| 2011-12-31 | $246.00M | +6.8% | 2014-02-27, Balance as of period end |
| 2010-12-31 | $230.40M | +11.3% | 2013-02-28, Balance as of period end |
| 2009-12-31 | $207.10M | n/a | 2012-02-29, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Bruker Corp (BRKR) | 2025-12-31 | $298.80M | +62.9% |
| Waters Corp (WAT) | 2025-12-31 | $587.83M | +80.7% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $919.86M | -20.9% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $529.80M | +8.5% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $365.40M | +39.5% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $1.79B | +34.6% |
| 10x Genomics, Inc. (TXG) | 2024-12-31 | $344.07M | -4.2% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $90.85M | -8.0% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $63.71M | +15.1% |
Compare BRKR, WAT, RVTY, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗